Compatibility of 17-α-Estradiol, Betamethasone, Finasteride, Melatonin, Prednicarbate, and Spironolactone in TrichoFoam™ - a Foaming Vehicle for Personalized Alopecia Treatments.
This study can further support the use of TrichoFoam™ as a viable vehicle for delivering multiple APIs in a personalized alopecia treatment regimen. The compatibility and stability of the APIs within this formulation offer a promising advancement in tailored alopecia treatments, potentially improving patient adherence and therapeutic outcomes.
Authors
- Bruna Marianni (ORCID: https://orcid.org/0000-0002-6809-3843)
- Hudson Polonini (ORCID: https://orcid.org/0000-0002-2119-3660)
Publication Details
- Journal
- PubMed
- Published
- 2024-12-06
- Primary Topic
- Hair Growth and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00